Magnus Life Science
London
About Magnus Life Science
Magnus Life Science: Where Blood Flow Matters Human disease will only be conquered by new ideas. Magnus has those ideas and employs a novel approach to the advancement and rapid development of valuable new discoveries in biomedicine. Every organ depends on the quality and quantity of the blood delivered to it. Disease is caused by interference with this process. Magnus Science has identified how to restore natural processes and establish health. This approach has come out of many years of deep research in one of the world’s leading universities, University College London. These ideas are completely original and powerful. Magnus has developed these ideas into new treatments for fetal conditions, heart disease and cancer which will be taken into patients in a rapid and focused way by Magnus scientists who are also practicing clinicians.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $24.9M
- Funding stage: Private Equity
- Last round: Private Equity (Oct 2014)
- Website: magnuslifescience.co.uk
- Phone: (440) 203-2827
Industries & Categories
Biopharma, Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/magnus-life-science-270147 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.